about
Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genesA European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsOnline information seeking by patients with bipolar disorder: results from an international multisite surveyThe CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal functionA genetic risk score is differentially associated with migraine with and without aura.The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional studyAssessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) ReportRenal function during long-term lithium treatment: a cross-sectional and longitudinal study.Clozapine toxicity due to a multiple drug interaction: a case report.Adverse drug reactions: role of pharmacogenomics.HDAC3 role in medication consumption in medication overuse headache patients: a pilot studyAssociation study between clinical response to rizatriptan and some candidate genes.Impact of sunlight on the age of onset of bipolar disorder.Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association studyAssociation study in three different populations between the GPR88 gene and major psychoses.Pharmacogenomics of bipolar disorder.Internet use by patients with bipolar disorder: Results from an international multisite survey.Influence of light exposure during early life on the age of onset of bipolar disorder.Cellular models to study bipolar disorder: A systematic review.International multi-site survey on the use of online support groups in bipolar disorder.Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study.Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour.Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database.Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.High leptin levels are associated with migraine with aura.Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite surveyCatechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
P50
Q28207979-8AB3693F-1498-44EC-ABAC-AF19B87A340AQ28554199-5E248088-5CC5-4680-8FA7-CB57ED0944A2Q28597389-D75C2564-1864-4ADC-8298-88201638DED3Q30433658-C1D61FCA-61EE-4663-A365-C3237C39B708Q33747916-FF2958E7-AFBF-499C-98DB-306EC30C2F19Q33760070-9E81F61E-DA20-4719-BE47-5624650765D9Q33885473-5F2F686D-5BB7-4718-9BFE-04A63B76740BQ33929926-3AA9DF62-9E52-4EF6-A9B4-27C811BFECA1Q34131354-0FD82BCB-78D2-4117-B8F3-DEE9D0ED023FQ34146222-D13389A7-1EAA-4F04-96AB-F0DDF9A0EE6CQ34582538-C443DFB7-2F8B-47E9-8516-AF8A967525D9Q34804607-D8E6E916-C243-4197-BE28-0C7D014E53A5Q34990769-6793BF8F-D114-4F3B-9E48-1F9A9CE77811Q35368023-3C2D394A-3CCE-4F75-9B77-BC684303DCEBQ35808356-FBD5E402-CFFC-4B04-A7C4-C066CA9BD5D7Q36255299-9B124BD9-AA1C-4DD8-A113-D3DF3B1A9C91Q36332449-B9062123-8B81-437C-B1A0-4409E663BA23Q36476154-6B44CBEC-99A9-49E6-BA7A-2ABD1739839CQ36746449-7900E65E-D0CE-495B-842A-337A03893EE1Q37649520-C1B23E78-4930-4739-AB45-E864BC3869F4Q38097534-E739E6E0-48E5-44FE-85CA-6BB8D3F69F0AQ38379000-535CB0F3-EDCC-493D-950E-8AA9A88CDD4FQ38415497-863C4ED3-A9D7-459D-9059-9935716D324DQ38526370-7C7BF9A8-B743-47E4-8676-BE1E6F9FC1BFQ38659298-F4E00FB0-BA03-48C7-A7AA-A13FBBCB1896Q38724876-79375514-B5A3-4CC4-B72A-A9BD757A8ED2Q38897295-541934C6-CC4C-4D5F-A510-2C2A19E573CFQ38903498-40C9DF96-094C-40AD-AA95-786EB1CC75B1Q39139500-320CFFF6-330A-42E7-AD89-37C52BD00B59Q39160232-813492A1-FF47-4827-8C9E-9D0310D71D5BQ39243622-235FD270-335D-433B-ADE9-09C7FEC7DD48Q39732399-00923D67-2755-48C7-A9A4-BE9FC3F1F711Q39846848-2B6A0E27-7CD6-48C6-8396-BB9BB3A106AFQ40760828-40465BB0-D9ED-4D0F-BC80-8DE3109F623FQ42320992-851C729B-4771-4B08-A25E-C82B15458723Q42368912-FDB6F180-25D6-4373-8D08-EC3385B0BC40Q42663078-CA9DE77C-EC6C-4598-BFC5-1E68443726ADQ43301014-2EB06053-DEF8-4B29-96B7-F70FAA459B7D
P50
description
onderzoeker
@nl
name
Maria Del Zompo
@ast
Maria Del Zompo
@en
Maria Del Zompo
@es
Maria Del Zompo
@nl
Maria Del Zompo
@sl
type
label
Maria Del Zompo
@ast
Maria Del Zompo
@en
Maria Del Zompo
@es
Maria Del Zompo
@nl
Maria Del Zompo
@sl
prefLabel
Maria Del Zompo
@ast
Maria Del Zompo
@en
Maria Del Zompo
@es
Maria Del Zompo
@nl
Maria Del Zompo
@sl